CLINICAL_TRIALS
trial_result
· 2021-04-08
Clinical Trial Update: Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90) [Phase 4]
Summary
A Phase 4 trial update investigating the minimal effective analgesic concentration (MEAC 90) of ropivacaine for femoral nerve block in postoperative pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Healthpoint Hospital | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN